Diabetic Nephropathies Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Diabetic Nephropathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Transformative Research in Diabetic Nephropathy

Diabetic NephropathiesDiabetic Glomerulosclerosis
University of Pennsylvania400 enrolled17 locationsNCT02986984
Recruiting

Transformative Research in Diabetic Nephropathy 2.0

Diabetes Mellitus, Type 2Kidney DiseasesDiabetic Nephropathies+1 more
University of Pennsylvania200 enrolled1 locationNCT07444203
Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Chronic Kidney DiseasesMolecular Sequence VariationAlbuminuria+4 more
Herlev Hospital300 enrolled13 locationsNCT04916132
Recruiting
Not Applicable

Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus MeSH:D003924Periodontitis MeSH:D010518Diabetic Nephropathies MeSH:D003928
Dow University of Health Sciences46 enrolled1 locationNCT07256613
Recruiting
Phase 4

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Chronic Kidney DiseaseDiabetic NephropathiesChronic Kidney Disease (Stages 4 and 5)+5 more
Ace Cells Lab Limited300 enrolled1 locationNCT07187713
Recruiting
Phase 3

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Heart FailureDiabetes Mellitus, Type 1Diabetic Nephropathies+1 more
Alessandro Doria150 enrolled18 locationsNCT06217302
Recruiting
Not Applicable

Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy

Diabetes Mellitus, Type 2Diabetic Nephropathies
Riphah International University60 enrolled1 locationNCT06778018
Recruiting
Phase 4

Efficacy and Safety of Telmisartan Compared With Losartan

HypertensionDiabetic Nephropathies
Chong Kun Dang Pharmaceutical98 enrolled1 locationNCT06431477
Recruiting

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

Type 1 DiabetesDiabetic Kidney DiseaseDiabetic Nephropathies+2 more
University of Colorado, Denver100 enrolled1 locationNCT05319990